Publication Name	World Journal of Nephrology
Manuscript ID	67699
Country	India

Received	2021-05-28 08:26
Peer-Review Started	2021-05-28 08:31
To Make the First Decision
Return for Revision	2021-07-31 04:20
Revised	2021-08-23 02:21
Second Decision	2022-03-29 02:02
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-04-04 06:44
Articles in Press	2022-04-04 06:44
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-03-21 02:34
Typeset the Manuscript	2022-05-18 02:40
Publish the Manuscript Online	2022-05-24 08:03

ISSN	2220-6124 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Minireviews
Article Title	Reno protective role of amlodipine in patients with hypertensive chronic kidney disease
Manuscript Source	Unsolicited Manuscript
All Author List	Georgi Abraham, A Almeida, Kumar Gaurav, Mohammed Yunus Khan, Usha Rani Patted and Maithrayie Kumaresan
Funding Agency and Grant Number
Corresponding Author	Mohammed Yunus Khan, MD, N/A, N/A, Medical Affairs, Dr. Reddys Labs, 7-1, 27, Ameerpet Rd, Leelanagar, Ameerpet,, Hyderabad 500016, Telangana, India. doctorkhan26@gmail.com
Key Words	Progression-free survival; overall survival; Gastric cancer; Albumin-to-alkaline phosphatase ratio
Core Tip	Amlodipine (ALM) is a powerful, well-tolerated, and safe anti-hypertensive agent widely used alone or as a key component of combination therapy for hypertension in chronic kidney disease (CKD). Its effectiveness in reducing blood pressure has proven benefits in cardiovascular event reduction and progression of renal disease. Overall, ALM emerges as the drug of choice in comparison to the newer calcium channel blockers in terms of its effectiveness and potency in BP lowering in CKD patients.
Publish Date	2022-05-24 08:03
Citation	Li YT, Zhou XS, Han XM, Tian J, Qin Y, Zhang T, Liu JL. Reno protective role of amlodipine in patients with hypertensive chronic kidney disease. World J Gastrointest Oncol 2021; 11(3): 86-95
URL	https://www.wjgnet.com/2220-6124/full/v11/i3/86.htm
DOI	https://dx.doi.org/10.5527/wjn.v11.i3.86

Full Article (PDF)	WJN-11-86.pdf
Full Article (Word)	WJN-11-86.docx
Manuscript File	67699_Auto_Edited-YXJW-FilipodiaCL.docx
Answering Reviewers	67699-Answering reviewers.pdf
Audio Core Tip	67699-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	67699-Conflict-of-interest statement.pdf
Copyright License Agreement	67699-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	67699-Language certificate.pdf
Peer-review Report	67699-Peer-review(s).pdf
Scientific Misconduct Check	67699-Bing-Wu YXJ-2.png
Scientific Editor Work List	67699-Scientific editor work list.pdf
CrossCheck Report	67699-CrossCheck report.pdf